drugset
drugset / Trial / NCT06840470

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

NCT06840470 ↗

Phase 4 Active not recruiting 40 enrolled University of Michigan
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being completed to determine if 8 weeks of treatment with imiquimod can shrink sebaceous hyperplasia.

Timeline

Start
2025-03-11
Primary completion
2026-12-31
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical

Indications

sebaceous gland disorder